[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Page 32961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-13389]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Demonstration Projects on 
Health Systems Change to Integrate Tobacco Dependence Treatment into 
Clinical Care and Assessment of Related Outcomes, Special Interest 
Projects (SIP)14-028; and Applied Research and Development of Tools to 
Address Point-of-Sale Tobacco Marketing, SIP14-029, Panel B, initial 
review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 9:00 a.m.-6:00 p.m., June 18, 2014 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Demonstration Projects on Health Systems Change to 
Integrate Tobacco Dependence Treatment into Clinical Care and 
Assessment of Related Outcomes, SIP14-028; and Applied Research and 
Development of Tools to Address Point-of-Sale Tobacco Marketing, 
SIP14-029, Panel B, initial review.''
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
    This notice is being published on less than 15 days prior to the 
meeting date because no earlier notification of the meeting was 
practicable.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-13389 Filed 6-6-14; 8:45 am]
BILLING CODE 4163-18-P